Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
09/15/2004 | CN1528228A New method for inhibiting flu and preventing SARS |
09/15/2004 | CN1528196A Broad-spectrum antibiotic antivirus complex chinese-western medicine-food dual-purpose nutrient for preventing and treating pharyngitis and preparing method thereof |
09/15/2004 | CN1166678C Purine derivatives |
09/15/2004 | CN1166668C Method for preparing substituted [1,4] diazepino (6,7,1-hi) indol-4-ones |
09/15/2004 | CN1166667C Imidazoimidazoles and trizoles as anti-inflammatory agents |
09/15/2004 | CN1166645C Bicyclic heterocyles, medicaments contg. these compounds, their use and methods for prodn. thereof |
09/15/2004 | CN1166643C 4-phenyl-pyrimidine derivatives |
09/15/2004 | CN1166629C Benzene sulfonamide compounds, its preparing method and medicinal compsns. contg. same |
09/15/2004 | CN1166618C New selective retinoid agonists |
09/15/2004 | CN1166408C Substrate tablet containing trimetzidine capable of long time controlled release after oral application |
09/15/2004 | CN1166405C Antiviral agent in form of nose drops |
09/15/2004 | CN1166401C Capsule for releiving cough and its preparation technology |
09/15/2004 | CN1166400C Drug for treating cold |
09/15/2004 | CN1166399C Medicine spray for treating throat disease and stomatopathy |
09/15/2004 | CN1166394C Chinese medicine for treating pharynigitis and globus hystericus and its prepn |
09/15/2004 | CN1166389C Inhalation liquor for treating common cold and its preparing process |
09/15/2004 | CN1166388C Medicine for treating nosal inflammation |
09/15/2004 | CN1166384C Medicine for relieving cough and asthma |
09/14/2004 | US6790989 Interleukin-1 beta converting enzyme/caspase; for prolonging viability of organs/cells for transplantation; for treating inflammatory, autoimmnune and neurodegenerative diseases; prevention of ischemic injury |
09/14/2004 | US6790941 Zinc finger protein derivatives and methods therefor |
09/14/2004 | US6790867 Combination of flunixin or the meglumine salt with a fluorinated chloramphenicol or thiamphenicol derivative antibiotic such as florfenicol |
09/14/2004 | US6790860 Pyrrolidine derivatives |
09/14/2004 | US6790850 Thiazolo(4,5-d)pyrimidine compounds |
09/14/2004 | US6790849 Methods and compositions using optically pure (-) cetirizine in combination with leukotriene inhibitors or decongestants |
09/14/2004 | US6790465 Composition and method for treating snoring |
09/14/2004 | CA2315826C Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
09/10/2004 | WO2004075988A2 Methods of immunomodulation in animals |
09/10/2004 | WO2004075920A1 Sustained-release pharmaceutical composition for lung administration |
09/10/2004 | WO2004075896A1 Medicament comprising a highly potent long-lasting beta2-agonist in combination with other active ingredients |
09/10/2004 | WO2004052847A3 Tricyclic steroid hormone nuclear receptor modulators |
09/10/2004 | WO2004022128A3 Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
09/10/2004 | WO2004014352A3 Methods for treating carbonic anhydrase mediated disorders |
09/10/2004 | WO2004009030A3 Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof |
09/10/2004 | WO2003003979A3 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
09/10/2004 | CA2517321A1 Medicament comprising a highly potent long-lasting beta2-agonist in combination with other active ingredients |
09/09/2004 | US20040176601 Benzimisazo[4,5-f]isoquinolinone derivatives |
09/09/2004 | US20040176595 Glucocorticoid receptor modulators |
09/09/2004 | US20040176473 Methods for delivering compounds into a cell |
09/09/2004 | US20040176456 Method of treatment for sexual dysfunction |
09/09/2004 | US20040176443 Capsaicin receptor ligands |
09/09/2004 | US20040176434 Pyrazoloanthrone derivatives as Jun N-terminal kinase inhibitors; diabetes; obesity |
09/09/2004 | US20040176433 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis |
09/09/2004 | US20040176422 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
09/09/2004 | US20040176421 such as 1,4-Bis-{N-[3-(3-aminomethylphenylproplonyl)-2-methoxycarbonylpyrrolidin-4-yl]aminocarbonyloxy}-2-butyne dihydrochloride; for treatment of asthma, allergic conjunctivitis, allergic rhinitis, psoriasis, and ulcerative colitis |
09/09/2004 | US20040176419 particularly chronic obstructive pulmonary disease (COPD), asthma or a related pulmonary disease such as chronic bronchitis or allergic rhinitis |
09/09/2004 | US20040176417 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands |
09/09/2004 | US20040176411 especially useful for treating asthma and/or rhinitis; example compound N-[[[2-[4-(3,4-dichlorophenoxy)-1-piperidinyl]ethyl]amino]carbonyl]-4-methyl-benzenesulfonamide |
09/09/2004 | US20040176400 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
09/09/2004 | US20040176389 Piperazine oxime dervatives having nk-1 receptor antagonistic activity |
09/09/2004 | US20040176386 Compounds |
09/09/2004 | US20040176382 treatment of inflammation, proliferative diseases, and certain cardiovascular disorders as well as Alzheimer's disease; |
09/09/2004 | US20040176365 1,8-Naphthyridin-2(1H)-one derivatives; antiasthmatic, antihistamine, and bronchodilator agents; nontoxic, side effect reduction |
09/09/2004 | US20040176363 N-Acylpiperazine derivatives; cardiovascular disorders; anticoagulants |
09/09/2004 | US20040176353 Derivatives of pyrimido[6,1-a]isoquinolin-4-one |
09/09/2004 | US20040176320 Use of at least one glycoinhibitor substance |
09/09/2004 | US20040176252 Well tolerated; intracellularly increasing cAMP; antiasthmatics, antiinflammatories: regulation of eosinophiles activation and degranulation |
09/09/2004 | US20040175803 Interferon-alpha induced gene |
09/09/2004 | US20040175422 excellent storage stability and little tendency to change the release rate of the pharmacologically active substance even after long-term storage; matrix comprising low-melting-point substance and pH-independent water-insoluble polymer |
09/09/2004 | US20040175419 controlling crystallization parameters of active ingredient to achieve increased compactability; compacting the active ingredient into a tablet |
09/09/2004 | US20040175363 Defective recombinant adenovirus; treatment of neurodenerative, cardiovascular, brain, genetic, nervous system and respiratory system disorders; Alzheimer's, Parkinson's, amyotrophic lateral sclerosis (ALS), atherosclerosis, and/or trisomy 2; adult respiratory distress syndrome; anticarcinogenic agents |
09/08/2004 | EP1454901A1 Piperazine compounds and pharmaceutical compositions containing them. |
09/08/2004 | EP1454898A1 Novel phenylalanine derivative |
09/08/2004 | EP1454897A1 PYRAZOLOPYRIMIDINONE DERIVATIVES HAVING PDE7−INHIBITORY ACTIVITY |
09/08/2004 | EP1453909A1 Cereal beta glucan compositions, methods of preparation and uses thereof |
09/08/2004 | EP1453832A1 Ring fused pyrazole derivatives |
09/08/2004 | EP1453829A1 Sulfonamido substituted imidazopyridines |
09/08/2004 | EP1453825A1 N-ureido-piperidines as antagonists viii for ccr-3 receptor |
09/08/2004 | EP1453820A1 Substituted 6h-dibenzo c,h]chromenes as estrogenic agents |
09/08/2004 | EP1453810A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same |
09/08/2004 | EP1453806A1 Aminotetralin derivatives as muscarinic receptor antagonist |
09/08/2004 | EP1453805A1 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists |
09/08/2004 | EP1453804A2 Ccr-3 receptor antagonists vii |
09/08/2004 | EP1453801A1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
09/08/2004 | EP1453798A2 (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses |
09/08/2004 | EP1453782A2 Substituted phenyl naphthalenes as estrogenic agents |
09/08/2004 | EP1453777A1 Functionalized higher diamondoids |
09/08/2004 | EP1453743A2 Pharmaceutical product with an adsorbent |
09/08/2004 | EP1453548A2 Compositions for and methods of treating and preventing sirs/sepsis |
09/08/2004 | EP1453547A2 Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor |
09/08/2004 | EP1453545A1 Water-soluble polymer conjugates of retinoic acid |
09/08/2004 | EP1453522A1 Methods for treatment or prophylaxis of aldosterone-mediated pathogenic effectgs in a subject using an epoxy-steroidal aldosterone antagonist |
09/08/2004 | EP1453515A2 Method to treat cystic fibrosis |
09/08/2004 | EP1453514A1 Piperazine derivatives for use as ccr-3 receptor antagonists in the treatment of asthma |
09/08/2004 | EP1453510A2 Neurotransmitter balance chemotherapy |
09/08/2004 | EP1453508A1 Tempamine compositions and use against cellular oxidative damage |
09/08/2004 | EP1453498A1 Use of a cysteine-containing substance to increase the ventilatory activity and erythropoietin production |
09/08/2004 | EP1453497A1 Use for the treatment of gastroesophageal reflux disease |
09/08/2004 | EP1453493A2 Reversible proton pump inhibitors for the treatment of airway disorders |
09/08/2004 | EP1453481A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents |
09/08/2004 | EP1345603A4 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
09/08/2004 | EP1292281B1 Novel tiotropium-containing inhalation powder |
09/08/2004 | EP1289972B1 Serine protease inhibitors |
09/08/2004 | EP1289950B1 Serine protease inhibitors |
09/08/2004 | EP1176971B1 Use of phyllanthus for treating chronic inflammatory and fibrotic processes |
09/08/2004 | EP1122243B1 Novel imidazoles with anti-inflammatory activity |
09/08/2004 | EP1079839B1 Therapeutic anti-cold agent containing isomalt as an active ingredient |
09/08/2004 | EP0994876B1 Quaternary ammonium compounds as tachykinin antagonists |
09/08/2004 | EP0623126B1 Imidazole derivatives and their use as cytokine inhibitors |
09/08/2004 | CN1527840A Use of CD 25 binding molecules in steroid-resistant patients |
09/08/2004 | CN1527838A Anti-inflammatory 17. beta-carbothioate ester derivatives of androstane with a cyclic ester group in position 17. alpha |